Kina review

Kina has a clearer audience than a general weight-loss storefront: women navigating menopause and midlife. Its weight offer combines several compounded formulations with ongoing care, while the wider catalog includes hormone services. That makes it relevant to Luna readers, but it does not establish that every product has the same clinical evidence or that hormone care is included in a weight prescription.

This review evaluates public prices and service descriptions rather than enrollment or treatment experience. We have not assigned a numerical fit score. The published offer is useful enough to compare, while several pharmacy, availability and refund details still need an individual answer.

What does Kina advertise for weight care?

The weight page advertises care starting at $169 for the first month, with ongoing semaglutide injection priced at $199 per month. Its ongoing alternatives are $279 for semaglutide oral dissolving tablets, $249 for tirzepatide injection and $229 for tirzepatide sublingual drops. The page says there is no separate membership fee, shipping is included and dose increases do not change the listed price. It identifies these as compounded treatments, not FDA-approved products. ¹

The introductory figure should not be used as the first-month price of every formulation. Obtain a written quote for the one the clinician proposes, including the amount charged, supply duration and next renewal. A per-month headline does not by itself establish whether every shipment or refill follows the same calendar interval.

How the care format works

Kina's FAQ describes an asynchronous intake, with video visits available, and a cash-pay model. It says patients can pause or cancel through their account without a long-term contract. Services depend on clinician licensure and pharmacy dispensing rules in the patient's state, rather than a published guarantee that all products are available nationwide. The FAQ identifies the clinical provider as Arora Health & Aesthetics. ²

This may suit someone comfortable writing a detailed history and using messages for follow-up. If you prefer a scheduled conversation before beginning, confirm how to request it and whether the proposed treatment waits until that visit. Also ask how clinical questions differ from order-support messages and what happens when the usual practitioner is unavailable. A fast intake is convenient, but the follow-up arrangement is what you will use throughout treatment.

What does the menopause focus add?

The wider Kina site connects weight care with separate hormone, sleep, skin, hair and longevity services. Its homepage presents treatment as clinician-guided and names medical leadership. That establishes a broader catalog, not proof that a single weight payment includes all those services or that every symptom should receive a hormone prescription. ³

Before paying, explain whether your priority is weight treatment, menopause symptom assessment or both. Ask whether the same practitioner handles the two and whether different prescriptions or testing create additional charges. Our GLP-1 and HRT guide helps frame coordination with an existing menopause clinician. Hormone therapy and weight medicine have different purposes; a menopause-focused brand should make those purposes easier to discuss, not blur them.

Check the assigned clinician and pharmacy

Kina's medical-team page attributes clinical decisions to Arora's licensed providers and says prescribing practitioners may hold MD, DO, NP or PA credentials. It also says that displaying Arora personnel does not imply endorsement of Kina's independent business practices. Leadership profiles are therefore different from the identity and qualifications of the clinician who reviews your case. ⁴

Request that practitioner's name and the dispensing pharmacy before fulfillment. Ask who monitors the plan, which records or labs are needed and how dose adjustments are communicated. A medical director's photograph cannot establish who will answer your messages. Our provider-selection guide offers a practical way to compare these responsibilities across services.

Oral formulations need product-specific questions

An oral dissolving tablet and drops are not automatically substitutes for an approved tablet or injection containing a related ingredient. FDA explains that it does not review compounded preparations for safety, effectiveness and quality before marketing. That does not establish the clinical performance of Kina's specific oral formats. ⁵ Ask the prescriber what evidence supports the exact preparation, how it is intended to be absorbed and why that formulation suits your medical history.

Also request the concentration, quantity, instructions, storage requirements and pharmacy label before using a compounded medicine. Do not infer dosing from a photograph or another clinic's vial. Our compounded-versus-brand guide explains the approval distinction and questions to bring to the clinician. A needle-free format can be appealing without having the same evidence as another product.

What remains to verify before payment?

We could not establish a complete medication-specific state list, a named pharmacy for every order or a full cancellation-and-refund cutoff from the reviewed public pages. The cancel-anytime presentation should therefore be checked against the actual checkout agreement. Ask whether cancellation stops the next processing order, whether an already prepared prescription can be refunded and whether the first-month discount changes on restart.

Kina's strongest reason to make a shortlist is the combination of midlife focus and visible formulation-specific prices without a separate access fee. Its main tradeoff is that the offered compounded formats need careful evidence and fulfillment checks. Compare that model with Evernow's menopause care, where access and prescriptions are separate, or use our menopause program comparison to decide which follow-up model fits your needs.